Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing Revision: v3.5.2. This indicates a minor update to the page's build/version metadata rather than a change to visible content.
    Difference
    0.0%
    Check dated 2026-04-30T15:29:14.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Cabozantinib Versus Sunitinib as Initial Targeted Therapy publication (CABOSUN trial) citation in Publications and removed the prior CABOSUN entry (revision v3.5.0).
    Difference
    0.1%
    Check dated 2026-04-16T11:00:38.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Padua, Italy, 35128 was replaced with Padova, Italy, 35128 in the locations section.
    Difference
    0.0%
    Check dated 2026-04-09T08:38:01.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The Napoli, Italy, 80131 site listing was changed to Naples, Italy, 80131. The city name now uses the English form.
    Difference
    0.0%
    Check dated 2026-03-25T21:23:40.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2026-03-18T17:52:50.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:58:58.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.